Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities
Irritable Bowel Syndrome (IBS) is a prevalent Gastrointestinal (GI) disorder, affecting approximately 10-15% of the global population, with significant implications for public health. It is characterised by chronic abdominal discomfort, altered bowel habits and a spectrum of symptoms that often co-e...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2025-01-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/20500/75633_CE(Ra1)_F(Sh)_QC(PS_OM)_PF1(AG_SS)_PFA(IS)_PB(AG_IS)_PN(IS).pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832593614012678144 |
|---|---|
| author | Bijita Bhowmick Sharmistha Banerjee Sanchaita Gayen Supriya Samanta Nilotpal Banerjee |
| author_facet | Bijita Bhowmick Sharmistha Banerjee Sanchaita Gayen Supriya Samanta Nilotpal Banerjee |
| author_sort | Bijita Bhowmick |
| collection | DOAJ |
| description | Irritable Bowel Syndrome (IBS) is a prevalent Gastrointestinal (GI) disorder, affecting approximately 10-15% of the global population, with significant implications for public health. It is characterised by chronic abdominal discomfort, altered bowel habits and a spectrum of symptoms that often co-exist with psychological conditions such as anxiety and depression. Emerging evidence highlights a critical imbalance in gut microbiota among individuals with IBS, underscoring the intricate gut-brain-microbiome axis. This dysbiosis not only exacerbates GI symptoms but also contributes to mental health challenges, creating a vicious cycle that impacts overall wellbeing. The broader consequences of IBS extend beyond individual health, leading to considerable impairment in daily functioning, reduced workplace efficiency and diminished Quality of Life (QoL). The socio-economic burden is reflected in increased rates of absenteeism, presenteeism and healthcare costs. Current therapeutic interventions, including probiotics, prebiotics, Faecal Microbiota Transplantation (FMT) and targeted medications, hold promise but require further research to establish their long-term efficacy and safety. This review aims to provide a comprehensive analysis of IBS, focusing on its microbial aetiology, the interplay with psychological co-morbidities, and its profound effects on work-related activities and societal productivity. By consolidating existing evidence, it seeks to emphasise the urgent need for innovative and effective therapeutic strategies. Addressing IBS as a multifaceted public health challenge requires interdisciplinary efforts to develop tailored interventions that alleviate its wide-ranging impacts on individuals and communities. |
| format | Article |
| id | doaj-art-5f5739dc92194529a38c0a68e23fe20c |
| institution | Kabale University |
| issn | 2249-782X 0973-709X |
| language | English |
| publishDate | 2025-01-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj-art-5f5739dc92194529a38c0a68e23fe20c2025-01-20T11:14:32ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-01-011901010610.7860/JCDR/2025/75633.20500Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbiditiesBijita Bhowmick0Sharmistha Banerjee1Sanchaita Gayen2Supriya Samanta3Nilotpal Banerjee4Research Assistant, Department of Pathology, Spandan Hospital, A Unit of Spandan Advance Medicare Pvt. Ltd., Kolkata, West Bengal, India.Counselling Psychologist, Department of Psychology, Spandan Hospital, A Unit of Spandan Advance Medicare Pvt. Ltd., Kolkata, West Bengal, India.Assistant Professor, Department of Medical Laboratory Technology, Eminent College of Management and Technology, Kolkata, West Bengal, India.Assistant Professor, Department of Medical Laboratory Technology, Eminent College of Management and Technology, Kolkata, West Bengal, India.Laboratory Director, Department of Pathology, Spandan Hospital, A Unit of Spandan Advance Medicare Pvt. Ltd., Kolkata, West Bengal, India.Irritable Bowel Syndrome (IBS) is a prevalent Gastrointestinal (GI) disorder, affecting approximately 10-15% of the global population, with significant implications for public health. It is characterised by chronic abdominal discomfort, altered bowel habits and a spectrum of symptoms that often co-exist with psychological conditions such as anxiety and depression. Emerging evidence highlights a critical imbalance in gut microbiota among individuals with IBS, underscoring the intricate gut-brain-microbiome axis. This dysbiosis not only exacerbates GI symptoms but also contributes to mental health challenges, creating a vicious cycle that impacts overall wellbeing. The broader consequences of IBS extend beyond individual health, leading to considerable impairment in daily functioning, reduced workplace efficiency and diminished Quality of Life (QoL). The socio-economic burden is reflected in increased rates of absenteeism, presenteeism and healthcare costs. Current therapeutic interventions, including probiotics, prebiotics, Faecal Microbiota Transplantation (FMT) and targeted medications, hold promise but require further research to establish their long-term efficacy and safety. This review aims to provide a comprehensive analysis of IBS, focusing on its microbial aetiology, the interplay with psychological co-morbidities, and its profound effects on work-related activities and societal productivity. By consolidating existing evidence, it seeks to emphasise the urgent need for innovative and effective therapeutic strategies. Addressing IBS as a multifaceted public health challenge requires interdisciplinary efforts to develop tailored interventions that alleviate its wide-ranging impacts on individuals and communities.https://jcdr.net/articles/PDF/20500/75633_CE(Ra1)_F(Sh)_QC(PS_OM)_PF1(AG_SS)_PFA(IS)_PB(AG_IS)_PN(IS).pdfmicrobiome-gut-brain axispsychological co-morbiditiesquality of lifework impairment |
| spellingShingle | Bijita Bhowmick Sharmistha Banerjee Sanchaita Gayen Supriya Samanta Nilotpal Banerjee Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities Journal of Clinical and Diagnostic Research microbiome-gut-brain axis psychological co-morbidities quality of life work impairment |
| title | Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities |
| title_full | Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities |
| title_fullStr | Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities |
| title_full_unstemmed | Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities |
| title_short | Irritable Bowel Syndrome: Gut Microbiota Dysbiosis and Psychological Co-morbidities |
| title_sort | irritable bowel syndrome gut microbiota dysbiosis and psychological co morbidities |
| topic | microbiome-gut-brain axis psychological co-morbidities quality of life work impairment |
| url | https://jcdr.net/articles/PDF/20500/75633_CE(Ra1)_F(Sh)_QC(PS_OM)_PF1(AG_SS)_PFA(IS)_PB(AG_IS)_PN(IS).pdf |
| work_keys_str_mv | AT bijitabhowmick irritablebowelsyndromegutmicrobiotadysbiosisandpsychologicalcomorbidities AT sharmisthabanerjee irritablebowelsyndromegutmicrobiotadysbiosisandpsychologicalcomorbidities AT sanchaitagayen irritablebowelsyndromegutmicrobiotadysbiosisandpsychologicalcomorbidities AT supriyasamanta irritablebowelsyndromegutmicrobiotadysbiosisandpsychologicalcomorbidities AT nilotpalbanerjee irritablebowelsyndromegutmicrobiotadysbiosisandpsychologicalcomorbidities |